As of 2025-07-06, the Intrinsic Value of Lucira Health Inc (LHDX) is -0.01 USD. This LHDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.45 USD, the upside of Lucira Health Inc is -101.22%.
Based on its market price of 0.45 USD and our intrinsic valuation, Lucira Health Inc (LHDX) is overvalued by 101.22%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.01 - -0.01 | -0.01 | -101.22% |
| P/E | 0.00 - 0.00 | 0.00 | -100.0% |
| DDM - Stable | 0.00 - 0.00 | 0.00 | -100.0% |
| DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
| Market Cap (mil) | 18.36 |
| Beta | 0.93 |
| Outstanding shares (mil) | 40.60 |
| Enterprise Value (mil) | 8.00 |
| Market risk premium | 5.00% |
| Cost of Equity | 13.59% |
| Cost of Debt | 5.00% |
| WACC | 9.30% |